1-3 of 3
Claire Tsao, PhD
Close
Sort by
Journal Articles

Final Results for the 1703 Phase 1b/2 Study of Elotuzumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Paul G. Richardson, Sundar Jagannath, MD, Philippe Moreau, MD, Andrzej Jakubowiak, MD PhD, Marc S Raab, MD PhD, Thierry Facon, MD, Ravi Vij, MD, Darrell White, MD, Donna E. Reece, MD, Lotfi Benboubker, MD PhD, Jeffrey Zonder, MD, L. Claire Tsao, PhD, Kenneth C. Anderson, MD, Eric Bleickardt, MD, Anil K Singhal, MD, Sagar Lonial, MD
Journal: Blood
Blood (2014) 124 (21): 302.
https://doi.org/10.1182/blood.V124.21.302.302
Published: 2014
Journal Articles

Elotuzumab In Combination with Lenalidomide and Dexamethasone In Patients with Relapsed Multiple Myeloma: Interim Results of a Phase 2 Study

Paul G. Richardson, MD, Philippe Moreau, MD, Andrzej J Jakubowiak, MD, PhD, Thierry Facon, MD, Sundar Jagannath, MD, Ravi Vij, MD, Donna E Reece, MD, Darrell J White, MD, Marc S Raab, MD, PhD, Lotfi Benboubker, MD, PhD, Jean-Francois Rossi, MD, PhD, Claire Tsao, PhD, John Fry, David Berman, MD, PhD, Anil K Singhal, MD, Sagar Lonial, MD
Journal: Blood
Blood (2010) 116 (21): 986.
https://doi.org/10.1182/blood.V116.21.986.986
Published: 2010
Journal Articles

Elotuzumab In Combination with Lenalidomide and Low-Dose Dexamethasone In Patients with Relapsed/Refractory Multiple Myeloma: Interim Results of a Phase 1 Study

Sagar Lonial, MD, Ravi Vij, MD, Jean-Luc Harousseau, MD, Thierry Facon, MD, Philippe Moreau, MD, Xavier Leleu, MD, PhD, Amitabha Mazumder, MD, Jonathan L Kaufman, MD, Christopher E Westland, Claire Tsao, PhD, Anil K Singhal, MD, Sundar Jagannath, MD
Journal: Blood
Blood (2010) 116 (21): 1936.
https://doi.org/10.1182/blood.V116.21.1936.1936
Published: 2010